Clinical Trial Update: Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab in biomarker-selected patients across multiple cancer types; recruitment is ongoing. Tumors are selected based on detectab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer
• Genitourinary Cancer
• Gynecologic Cancer
• Head and Neck Cancer
• Lung Cancer
• Sarcoma
• Skin Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Breast Cancer, Lung Cancer | Phase 2 | Status: RECRUITING